The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics
Yulian Mytsyk, Yosyf Nakonechnyi, Victor Dosenko, Paweł Kowal, Michał Pietrus, Katarína Gazdíková, Monika Labudová, Martin Čaprnda, Robert Prosecký, Jozef Dragašek, Peter Kružliak, Roman Dats
Topics & Concepts
TMPRSS2Prostate cancerPCA3ErgMedicineProstatitisInternal medicineProstateUrinary systemProstate biopsyUrologyUrineOncologyReceiver operating characteristicBiopsyCancerOphthalmologyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)RetinalCancer-related molecular mechanisms researchProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research